Financial Summary (All financials)
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-05-20 | Jun-30-19 | Jun-05-19 | Jun-30-18 |
| Revenues | 5,554.1 | 5,304.4 | 4,629.9 | 4,717.8 | 4,717.8 | 6,287.9 | 6,287.9 | 9,398.0 |
| Revenue growth | 4.7% | 14.6% | -1.9% | -25.0% | -25.0% | -33.1% | -8.1% | 22.8% |
| Cost of goods sold | 2,006.8 | 1,935.2 | 1,861.7 | 1,991.2 | 1,991.2 | 2,498.5 | 2,498.5 | 3,607.8 |
| Gross profit | 3,547.3 | 3,369.2 | 2,768.2 | 2,726.6 | 2,726.6 | 3,789.4 | 3,789.4 | 5,790.2 |
| Gross margin | 63.9% | 63.5% | 59.8% | 57.8% | 57.8% | 60.3% | 60.3% | 61.6% |
| Selling, general and administrative | 2,818.3 | 2,881.3 | 2,363.2 | 3,120.0 | 3,120.0 | 3,467.9 | 3,467.9 | 5,018.1 |
| EBITA | 729.0 | 473.2 | 266.2 | -550.7 | -439.2 | 321.5 | 321.5 | 772.1 |
| EBITA margin | 13.1% | 8.9% | 5.7% | -11.7% | -9.3% | 5.1% | 5.1% | 8.2% |
| Amortization of intangibles | 191.8 | 207.4 | 251.2 | 233.1 | 233.1 | 246.7 | 246.7 | 352.8 |
| EBIT | 537.2 | 265.8 | 15.0 | -783.8 | -672.3 | 74.8 | 74.8 | 419.3 |
| EBIT margin | 9.7% | 5.0% | 0.3% | -16.6% | -14.3% | 1.2% | 1.2% | 4.5% |
| Pre-tax income | 704.8 | 426.8 | -239.8 | -1,467.6 | -1,467.6 | -3,945.4 | -3,945.4 | -152.5 |
| Income taxes | 181.6 | 164.8 | -172.0 | -377.7 | -464.9 | -54.8 | -175.8 | -24.7 |
| Tax rate | 25.8% | 38.6% | 71.7% | 25.7% | 31.7% | 1.4% | 4.5% | 16.2% |
| Earnings from continuing ops | 495.0 | 55.5 | -166.3 | -1,100.4 | -1,093.9 | -3,905.2 | -3,905.2 | -127.8 |
| Earnings from discontinued ops | | 5.7 | -137.3 | 87.2 | 87.2 | 121.0 | 121.0 | |
| Net income | 495.0 | 61.2 | -303.6 | -1,013.2 | -1,006.7 | -3,784.2 | -3,784.2 | -127.8 |
| Net margin | 8.9% | 1.2% | -6.6% | -21.5% | -21.3% | -60.2% | -60.2% | -1.4% |
| |
| Diluted EPS | $0.56 | $0.07 | ($0.22) | ($1.45) | ($1.44) | ($5.20) | ($5.20) | ($0.17) |
| Shares outstanding (diluted) | 886.5 | 834.1 | 764.8 | 759.1 | 759.1 | 751.2 | 751.2 | 749.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|